US  Authorizes Lower Dose of Regeneron ' s COVID-19 Antibody Therapy US  Authorizes Lower Dose of Regeneron ' s COVID-19 Antibody Therapy

Regeneron said on Friday the US health regulator updated the emergency use authorization for its cocktail of two antibodies to treat COVID-19, allowing its use at half the originally authorized dose.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news